Dear all, I am proud to announce that Arcana Institute (INAR), together with Analytica Laser, is now part of Certara, a global leader in model-informed drug development and regulatory science. Arcana Institute, together with Analytica Laser and other companies acquired by Certara, provides

Optimize the use of your existing data & materials on a product to build your HTA Master File for local submissions in CEE countries! The HTA Master File is a useful resource when a company already has existing material and data on

3rd Health Challenges Congress (HCC) 2018 Dr. Jacek Walczak, President of Arcana Institute, recently participated in the 3rd Health Challenges Congress in Katowice, Poland on 8-10 March 2018. During a session on the ‘Health Status of the Population and its

The latest results of the periodic Analysis of the Reimbursement Decision-Making Practice of AHTAPol and the Minister of Health The results include the notice of the Minister of Health from 26 February 2018, effective 1st March 2018. We track the

Our Findings Help Inform You on Next Step Decision-Making and Planning for Your Drug or Medical Device Our Approach Information from the validation of surrogate endpoints is used for decision-making at the company level or by HTA agencies for reimbursement. Our approach for validation of surrogate

The latest results of the periodic Analysis of the Reimbursement Decision-Making Practice of AHTAPol and the Minister of Health The results include the notice of the Minister of Health from 21 December 2017, effective 1st January 2018. We track the Minister of Health’s reimbursement

Value-Driven Health Care There is a growing recognition of value demonstration and HTA for procurement and reimbursement of medical devices in hospitals and health systems alike. In contrast to a solely price-based strategy, value-based payment strategies incorporate measures such as outcomes (including health,

Expert Discussion on Public Procurement of Medical Technologies in Hospitals in Poland by Dziennik Gazeta Prawna Karolina Skóra, COO at Arcana Institute, recently participated in a panel discussion on the procurement of medical technologies for hospitals. The discussion was hosted and

As part of Arcana Institute’s participation in the XV International Conference of the Polish Pharmacoeconomics Society (ISPOR Poland Chapter) held on 30 Nov – 1st Dec 2017 in Warsaw, Poland, our team prepared two posters to share. Click on the

The Polish Pharmacoeconomics Society (PTFE), ISPOR Poland Chapter, is organizing its XV Annual International Conference with the topic of “Drug Pricing in Europe – Fair, Uniform or Both?” The conference will take place 30 Nov – 1st Dec 2017 in